Astrocyte-elevated gene-1 (AEG-1) has been reported to be upregulated in several malignancies and play a critical role in Ha-ras-mediated oncogenesis through the phosphatidylinositol 3-kinase/AKT signaling pathway. However, the role of AEG-1 in prostate cancer (PC) has never been reported. We now show that AEG-1 is overexpressed in clinical PC tissue samples and cultured PC cells compared to benign prostatic hyperplasia tissue samples and normal prostate epithelial cells. Interestingly, AEG-1 knockdown induced cell apoptosis through upregulation of forkhead box (FOXO) 3a activity. This alteration of FOXO3a activity was dependent on reduction of AKT activity in LNCaP and PC-3 cells with high constitutive AKT activity, but not in DU145 cells with low constitutive AKT activity, although AEG-1 knockdown had no impact on phosphatase and tensin homolog expression in these cells. AEG-1 knockdown also attenuated the constitutive activity of the nuclear factor jB (NF-jB) and the activator protein 1 (AP-1) with a corresponding depletion in the expression of NF-jB and AP-1-regulated genes (interleukin (IL)-6, IL-8 and matrix metalloproteinase-9) and significantly decreased cell invasion properties of PC-3 and DU145 cells. Overall, our findings suggest that aberrant AEG-1 expression plays a dominant role as a positive auto-feedback activator of AKT and as a suppressor of FOXO3a in PC cells. AEG-1 may therefore represent a novel genetic biomarker to serve as an attractive molecular target for new anticancer agents to prevent PC cell progression and metastasis.
Introduction
AKT (AKT8 virus oncogene cellular homolog) is a serine/threonine protein kinase functioning downstream of phosphatidylinositol 3-kinase (PI3K) in response to mitogen or growth factor stimulation. High levels of AKT activation have been associated with the development and metastasis of several cancers including prostate cancer (PC) (Nicholson and Anderson, 2002) . AKT activation not only directly inhibits apoptosis by multiple mechanisms involved in inhibiting the conformational change of Bax, BAD and caspase-9, but also modulates apoptosis indirectly by influencing the activities of several transcription factors, including fork head transcription factors (forkhead box, FOXO) and nuclear factor kB (NF-kB) (Alessi et al., 1997) .
The FOXO3a protein has been reported to be the most highly expressed FOXO family member in PC cells and implicated in the transcriptional regulation of p27 KIP1 (Lynch et al., 2005) . NF-kB is an inducible transcription factor that can regulate a diverse number of genes involved in proliferation, apoptosis, inflammation and the immune response (Ghosh and Karin, 2002) . In most cell types, NF-kB is predominantly a heterodimer composed of the p50 and p65 subunits (Place et al., 2005) . Constitutive activation of NF-kB is found in many types of solid tumors (Lu et al., 2004; Nakashima et al., 2006) . Other transcriptional regulators whose activities are affected by PI3K/AKT signaling include MIZ-1, p53, activator protein 1 (AP-1), c-Myc, b-catenin and HIF1a (Bader et al., 2005) . The exact roles of these proteins during PI3K/AKT-mediated oncogenesis are currently unknown, but they have all been linked to oncogenic transformation (Lee et al., 2006) .
The constitutive activation of NF-kB and AP-1 have been reported to be essential for deregulated interleukin (IL)-6 expression, which has been implicated in PC and resistance to chemotherapy and has been directly linked to PC morbidity and mortality (Zerbini et al., 2003) . On the other hand, the tumor suppressor PTEN (phosphatase and tensin homolog) negatively regulates the activity of AKT (Damen et al., 1996) .
Recently, astrocyte-elevated gene-1 (AEG-1) was originally characterized as an HIV-1-inducible gene in primary human fetal astrocytes (Su et al., 2002 (Su et al., , 2003 Kang et al., 2005) . Although AEG-1 is ubiquitously expressed in numerous cell types, elevated levels have been observed in some solid tumors including breast, brain and prostate (Brown and Ruoslahti, 2004) . AEG-1 overexpression has also been reported to be induced by oncogenic Ha-ras through the PI3K/AKT signaling pathway (Lee et al., 2006) and to enhance the tumorogenic properties of cultured HeLa cells by activating the NF-kB pathway . However, such studies are lacking in PC.
In the present study, we suggest a new molecular mechanism that aberrant AEG-1 expression plays a dominant role as a positive auto-feedback activator of AKT and as a suppressor of FOXO3a to promote PC progression.
Results
Immunostaining of AEG-1 in human PC specimens In order to examine the expression levels of AEG-1 in malignant and nonmalignant prostate tissues, immunostaining was performed on 20 PC and 20 benign prostatic hyperplasia (BPH) specimens using antibody to AEG-1. Typical immunostaining of AEG-1 in BPH (a) and PC (b) specimens are shown in Figure 1A . PC cells in the tumor tissues that comprise small glandular structures are almost completely positive. The expression levels were scored as 2 þ . Strongly positive expression was observed in 80% of the PC specimens compared with 10% of the BPH specimens. In contrast, negative or weakly positive expression in PC specimens was significantly lower than that in BPH specimens (0 or 20 vs 55 or 35%, respectively) as shown in Figure 1B .
Expression of AEG-1 is enhanced in PC cells
In order to determine relative expression levels of AEG-1 in PC cells, equivalent quantities of RNA and protein were analysed by quantitative real-time reverse transcription (RT)-PCR and western blotting, respectively. As shown in Figures 1C and D, mRNA and protein expression levels of AEG-1 were approximately three times greater in PC cells than in normal RWPE-1 cells. Furthermore, a significant difference in these expression levels was also observed between LNCaP and PC-3 or DU145 cells. 
AEG-1 knockdown reduces cell viability and promotes apoptosis in PC cells
In order to examine the role of AEG-1 on PC cell proliferation, we examined the effect of AEG-1 PMO on PC cell viability. As shown in Figures 3A and B, AEG-1 PMO significantly decreased PC cell viability in a timedependent manner. However, RWPE-1 cell viability remained relatively unchanged following AEG1 PMO treatment. We also evaluated apoptotic levels by using flow cytometry. As shown in Figures 3C and D, the apoptotic cell fractions were 4, 5 and 5% in untreated LNCaP, PC-3 and DU145 cells, respectively. In contrast, 22, 38 and 38% were apoptotic when cells were transfected with AEG-1 PMO.
AEG-1 knockdown downregulates constitutive AKT activity AKT activity was decreased in AEG-1 PMO-transfected LNCaP and PC-3 cells compared to untreated control cells with high constitutive AKT activity, although no impact of AEG-1 knockdown on AKT activity was seen in DU-145 cells with low constitutive AKT activity. These reductions in AKT activity were not due to the induction of PTEN. In addition, AEG-1 knockdown did not affect the level of PTEN in DU145 cells ( Figure 4a ).
AEG-1 knockdown upregulates FOXO3a activity
As shown in Figure 4b , FOXO3a expression levels in PC-3 and DU145 cells were much lower than that in LNCaP cells. AEG-1 blockade increased FOXO3a and FOXO3a-responsive p27 KIP1 protein expression in each cell line. AEG-1 PMO also caused an accumulation of FOXO3a in the nucleus with a corresponding depletion of both FOXO3a and p-FOXO3a in the cytoplasm (Figure 4c ). LNCaP cells. Composition of the DNA-protein complexes in NF-kB was determined by supershift experiments using antibodies specific to the p65 and p50 NF-kB subunits (Figure 5b ). To confirm the functional impact of NF-kB and AP-1 inactivation by AEG-1 PMO on gene regulation, the expression of NF-kB and AP-1-regulated genes IL-6, IL-8 and matrix metalloproteinase-9 (MMP-9) were analysed by quantitative real-time RT-PCR and immunoblotting. As shown in Figures 5d and e, the mRNA and protein expression levels for each gene declined significantly by AEG-1 knockdown in PC-3 and DU145 cells, although no impact on each gene expression was seen in LNCaP cells.
AEG-1 knockdown downregulates constitutive NF-kB and AP-1 activities

AEG-1 knockdown decreases cell invasion properties
As shown in Figures 6A and B, AEG-1 knockdown by PMO significantly decreased the invasive ability of PC-3 and DU145 cells by B69 and B67%, respectively compared to untreated cells. However, AEG-1 PMO had no impact on the invasive properties of LNCaP cells.
Discussion
The poor prognosis for androgen-independent advanced PC reflects in part the lack of knowledge about the tumor's basic biology. The present study demonstrates a new molecular mechanism that aberrant AEG-1 expression in PC cells plays a dominant role as a positive autofeedback activator of AKT and as a suppressor of FOXO3a to promote PC progression. Additionally, we provide experimental evidence that aberrant AEG-1 expression also contributes to the upregulation of constitutive NF-kB and AP-1 activity to enhance the Knockdown of AEG-1 in human prostate cancer N Kikuno et al invasive properties in androgen-insensitive PC-3 and DU145 cells. AKT is activated constitutively in LNCaP that is a PTEN-null androgen-sensitive PC cell line (Yang et al., 2005) . AKT also regulates many of the processes associated with metastatic progression, and the emergence of androgen-independent PC cells (Nakatani et al., 1999; Chen et al., 2001) . NF-kB, AP-1, c-MYC and b-catenin are activated whereas FOXO, MIZ1 and p53 are inactivated by AKT signaling (Bader et al., 2005) . On the other hand, constitutive activation of NFkB and AP-1 has been reported in PC-3 and DU145 cells, but not in LNCaP (Zerbini et al., 2003) , and it has been reported that multiple survival signals converge on FOXO in PC cells based on the fact that DU145 cells do not die despite the lack of active AKT due to intact PTEN (Li et al., 2003) . These previous studies indicate that signaling pathways other than PI3K/AKT influence the constitutive activation of NF-kB and AP-1 or inactivation of FOXO in androgen-insensitive PC cells.
Aberrant AEG-1 expression has been observed in some solid tumors including breast, brain and prostate (Brown and Ruoslahti, 2004) . In this study, we confirmed that AEG-1 expression was increased in human PC tissues and cultured cells compared to BPH tissues and normal prostate epithelial cells, respectively (Figure 1 ). Therefore, we tested the hypothesis that AEG-1 plays an important role with PI3K/AKT-related proteins to promote PC progression. Interestingly, AEG-1 knockdown by PMO significantly reduced cell proliferation and viability in both androgen-sensitive and -insensitive PC cells by inducing apoptosis (Figure 3 ). These data indicate that AEG-1 knockdown effects not only the NF-kB signaling pathway, but also the PI3K/AKT signaling pathway either directly or indirectly and also influences the function of several PI3K/AKT downstream substrates. There are some reports about growth inhibition and apoptosis induction due to blockade of constitutive PI3K/AKT activity in PC cells, although it is known that inhibition of NF-kB in cancer cells by stable transfection of IkBaM does not inhibit cell growth or induce apoptosis per se (BentiresAlj et al., 1999; Pajonk et al., 1999) . For example, the direct blockade of AKT activation has been reported to inhibit cell proliferation and induce apoptosis in LNCaP, PC-3 and DU145 cells (Festuccia et al., 2005; Zhang et al., 2007) .
To elucidate the precise molecular mechanism underlying the cooperation between AEG-1 and PI3K/AKTrelated proteins in PC cells, we focused on the alteration of AKT, NF-kB, AP-1 and FOXO activities accompanying changes in PTEN expression in AEG-1 knockdown PC cells. Our results in Figure 4 support previous reports that multiple survival signals including the PI3K/AKT signaling pathway converge on FOXO forkhead factors and reduced FOXO function might play a role in the androgen-independent progression of PC cells (Li et al., 2003) . AKT may also phosphorylate FOXO at multiple sites forcing FOXO to the cytoplasm (Biggs et al., 1999; Takaishi et al., 1999) and promoting proteosomal degradation of FOXO3a, thereby suppressing FOXO3a function (Plas and Thompson, 2003) . Overall, these results may indicate that AEG-1 plays an important role as a direct positive auto-feedback activator for the PI3K/AKT signaling pathway in LNCaP and PC-3 cells and as direct suppressor of FOXO3a activity in DU145 cells, enhancing cancer progression independent of AKT activity and high PTEN expression. AEG-1 knockdown also attenuated the constitutive NF-kB and AP-1 activities (Figures 5a  and c) and the cell invasive properties of androgeninsensitive PC-3 and DU145 cells (Figure 6 ). These results suggest that AEG-1 might be important for the constitutive activation of NF-kB and AP-1 in androgeninsensitive PC cells leading to enhanced cancer cell viability and invasion. AEG-1 may therefore represent a novel genetic biomarker to serve as an attractive molecular target for new anticancer agents to prevent PC cell progression and metastasis. media supplemented with 50 mg/ml bovine pituitary extract, 50 U/ml penicillin and 50 mg/ml streptomycin. All cells were cultured in a humidified atmosphere of 5% CO 2 /95% air at 371C.
Immunohistochemistry
Immunostaining of AEG-1 was done using anti-AEG-1 antibody (Invitrogen, Carlsbad, CA, USA). Negative controls were done using non-specific immunoglobulin. A pathologist not involved in the present study evaluated the immunostaining under blind conditions. The immunohistochemical staining was graded on an arbitrary scale from 0 to 2 þ ; 0 representing negative expression (0-20% positive cells), 1 þ representing weakly positive expression (20-50% positive cells) and 2 þ representing strongly positive expression (50-100% positive cells). The scale was determined according to the average number of positive cells in ten random fields of all slides.
AEG-1 knockdown by PMO transfection
An antisense PMO molecule (5 0 -AATCTCTTATACT CACCTTTTGATC-3 0 ) was designed and synthesized against the exon 8-intron 8 junction of the pre-mRNA AEG-1 transcript (Gene Tools, LLC, Corvallis, OR, USA). The PMO resulted in the functional knockdown of AEG-1 by promoting improper splicing and removal of exon 8 from the mature transcript. Primers targeting exon 8 (forward primer; AEG-1-S) and exon 10 (reverse primer; AEG-1-AS) were used to determine AEG-1 knockdown by PMO (sequences in Table 1 ). A control PMO molecule was also synthesized that contained 5 mismatched base pairs (5 0 -AATgTgTTATAgT CACgTTTTcATC-3 0 ). Cells were transfected with AEG-1 or control PMO for 48 h using the Endo-Porter delivery system (Gene Tools, LLC, Corvallis, OR, USA) according to the manufacturer's protocol.
Quantitative real-time RT-PCR Total RNA was extracted using the RNeasy RNA isolation kit (Qiagen, Velencia, CA, USA). Total RNA was reverse transcribed using SuperScript reverse transcriptase and oligo (dT) primers (Invitrogen). The resulting cDNA samples were amplified by quantitative real-time RT-PCR in the presence of SYBR Green PCR Master Mix (Applied Biosystems, Foster, CA, USA) using primers specific for AEG1, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), IL-6, IL-8 and MMP-9 (Table 1) . Levels of mRNA were expressed relative to the amount of the constitutively expressed GAPDH.
Protein extraction and immunoblotting
Nuclear and cytoplasmic proteins were isolated using the CelLyticTM NuCLEARTM Extraction kit (Sigma, St Louis, MO, USA). Protein concentrations were determined by the Bradford method (Bradford, 1976) . Equal amounts of protein were resolved on 10% sodium dodecyl sulfate polyacrylamide gels and transferred to nitrocellulose by voltage gradient transfer. The resulting blots were blocked with 2% nonfat dry milk and probed with antibodies specific for AEG-1, p-Akt (Ser473), Akt, PTEN, p-FOXO3a (Ser253), FOXO3a, p27 Kip1 , IL-6, IL-8, MMP-9 or EF1a. Protein expression levels were depicted as their relative yield to the EF1a level.
Cell viability assay
Following transfection with or without AEG-1 or control PMO for 48 h, cells were transferred to 96-well microplates and seeded at a density of 5 Â 10 3 cells per well. After 24, 48 and 72 h, cell viability was determined by using the CellTiter 96 AQueous One Solution Cell Proliferation Assay kit (Promega, Madison, WI, USA) according to the manufacturer's protocol.
Flow cytometry
Detection of apoptosis by flow cytometry was performed using the ApoScreen Annexin V-FITC kit (Southern Biotech, Birmingham, AL, USA). The staining was performed according to the producer's manual. Flow cytometry (Becton Dickinson, San Jose, CA, USA) was performed immediately after staining.
Electrophoretic mobility shift assay DNA-binding assays were performed using the LightShift Chemiluminescent EMSA kit (PIERCE Biotechnology, Rockford, IL, USA) according to the manufacture's protocol. Resulting bands were quantified by optical densitometry using ImageJ software version 1.36b and indicated as arbitrary density units. Supershift analyses were performed using antibodies against p65 and p50 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) to demonstrate specificity of the electrophoretic mobility shift assay results.
In vitro invasion assay Invasion studies were conducted using the BioCoat Matrigel Invasion Chambers (BD Biosceinces, Bedford, MA, USA). Cells were incubated for 24 h at 371C in a 5% CO 2 atmosphere. Those cells that migrated through the membrane to the lower surface were stained with Hema-3 (Fisher Scientific, Middletown, VA, USA), and counted. Knockdown of AEG-1 in human prostate cancer N Kikuno et al
Statistical analysis
Statistical analysis was performed using one-way ANOVA followed by the Fisher's protected least-significant-difference test. A P-value of o0.05 was considered statistically significant.
Abbreviations
AEG-1, astrocyte-elevated gene-1; AP-1, activator protein 1; FOXO, forkhead box; IL-6, Interleukin-6; IL-8, Interleukin-8; MMP-9, matrix metalloproteinase-9; NF-kB, nuclear factor kB; PI3K, phosphatidylinositol 3-kinase; PMO, phosphorodiamidate morpholino antisense oligonucleotide; PTEN, phosphatase and tensin homolog.
